InsiderTrades.com logo

TERN Insider Trading

Insider Ownership Percentage: 1.50%
Insider Buying (Last 12 Months): $186,575.18
Insider Selling (Last 12 Months): $7,018,552.57

Terns Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Terns Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Terns Pharmaceuticals Share Price & Price History

Current Price: $49.61
Price Change: ▲ Price Increase of +1.17 (2.42%)
As of 03/23/2026 05:00 PM ET

This chart shows the closing price history over time for TERN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Terns Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/16/2026Amy L BurroughsCEOSell14,583$46.71$681,171.93288,976View SEC Filing Icon  
2/17/2026Amy L BurroughsCEOSell14,583$39.19$571,507.77288,976View SEC Filing Icon  
1/15/2026Amy L BurroughsCEOSell68,749$37.07$2,548,525.43288,976View SEC Filing Icon  
1/5/2026Amy L BurroughsCEOSell71,339$38.10$2,718,015.90138,976View SEC Filing Icon  
1/2/2026Emil KuriakoseInsiderSell1,155$38.57$44,548.3550,365View SEC Filing Icon  
11/4/2025Jill M QuigleyDirectorSell24,520$18.00$441,360.00View SEC Filing Icon  
10/1/2025Emil KuriakoseInsiderSell944$7.85$7,410.4051,520View SEC Filing Icon  
7/1/2025Emil KuriakoseInsiderSell853$4.27$3,642.3152,464View SEC Filing Icon  
6/27/2025Andrew GengosCFOBuy10,000$3.93$39,300.0025,000View SEC Filing Icon  
6/25/2025Amy L BurroughsCEOBuy23,314$3.87$90,225.1847,083View SEC Filing Icon  
6/16/2025Andrew GengosCFOBuy5,000$3.95$19,750.0015,000View SEC Filing Icon  
6/13/2025Andrew GengosCFOBuy10,000$3.73$37,300.0010,000View SEC Filing Icon  
4/1/2025Emil KuriakoseInsiderSell952$2.49$2,370.4853,317View SEC Filing Icon  
1/6/2025Jill M. QuigleyDirectorSell8,760$5.79$50,720.40View SEC Filing Icon  
1/6/2025Mark J VignolaCFOSell9,059$5.80$52,542.2074,752View SEC Filing Icon  
1/2/2025Emil KuriakoseInsiderSell4,481$5.71$25,586.5154,269View SEC Filing Icon  
1/2/2025Jill M QuigleyDirectorSell6,240$5.72$35,692.808,760View SEC Filing Icon  
1/2/2025Mark J VignolaCFOSell8,129$5.72$46,497.8883,811View SEC Filing Icon  
12/5/2024Amy L BurroughsCEOBuy15,450$7.15$110,467.5019,099View SEC Filing Icon  
11/30/2024Amy L BurroughsCEOBuy510$5.11$2,606.1019,609View SEC Filing Icon  
11/30/2024Melita Sun JungInsiderBuy2,250$5.11$11,497.502,250View SEC Filing Icon  
9/12/2024Hongbo LuDirectorBuy476,190$10.50$4,999,995.00476,190View SEC Filing Icon  
9/10/2024Mark J VignolaCFOSell10,000$11.00$110,000.0091,940View SEC Filing Icon  
9/9/2024Jill M QuigleyDirectorSell17,235$10.00$172,350.0015,000View SEC Filing Icon  
8/1/2024Jill M QuigleyDirectorSell6,143$7.68$47,178.2423,857View SEC Filing Icon  
7/15/2024Carl L GordonDirectorSell50,976$10.00$509,760.00756,258View SEC Filing Icon  
4/3/2024Vivo Opportunity, LlcMajor ShareholderSell138,066$6.20$856,009.20268,573View SEC Filing Icon  
4/1/2024Vivo Opportunity, LlcMajor ShareholderSell181,117$6.99$1,266,007.83275,772View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Terns Pharmaceuticals (NASDAQ:TERN)

98.26% of Terns Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TERN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Terns Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/16/2026Avoro Capital Advisors LLC4,350,000$175.74M1.7%N/A4.192%Search for SEC Filing on Google Icon
2/26/2026Seven Fleet Capital Management LP36,894$1.49M1.1%N/A0.036%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.606,247$24.49M0.0%+26.9%0.584%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp5,295$0.22M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC9,173$0.37M0.0%+240.0%0.009%Search for SEC Filing on Google Icon
2/18/2026ADAR1 Capital Management LLC541,615$21.88M1.6%+5,316.2%0.522%Search for SEC Filing on Google Icon
2/18/2026KVP Capital Advisors LP440,000$17.78M17.2%N/A0.424%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd17,032$0.69M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/18/2026Ikarian Capital LLC1,596,378$64.49M5.0%+872.2%1.539%Search for SEC Filing on Google Icon
2/18/2026Vestal Point Capital LP4,500,000$181.80M6.2%N/A4.337%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC5,912$0.24M0.1%-79.6%0.006%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP788,659$31.86M0.0%+211.2%0.760%Search for SEC Filing on Google Icon
2/18/2026Squadron Capital Management LLC190,000$7.68M3.3%N/A0.183%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.215,854$8.72M0.3%+1,744.0%0.208%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL73,246$2.96M0.0%N/A0.071%Search for SEC Filing on Google Icon
2/18/2026Superstring Capital Management LP443,777$17.93M9.6%-43.8%0.428%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd67,266$2.72M0.0%N/A0.065%Search for SEC Filing on Google Icon
2/18/2026Orbimed Advisors LLC2,153,300$86.99M1.8%-71.5%2.075%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC987,306$39.89M0.0%+4.9%0.952%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC3,379,569$136.50M0.1%N/A3.257%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC11,476$0.46M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP16,765$0.68M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/18/2026Evergreen Quality Fund GP Ltd.360,200$14.55M0.3%N/A0.347%Search for SEC Filing on Google Icon
2/18/2026Capitolis Liquid Global Markets LLC3,045,200$123.03M0.7%N/A2.935%Search for SEC Filing on Google Icon
2/18/2026Catalio Capital Management LP136,958$5.53M1.0%N/A0.132%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP70,159$2.83M0.2%-9.5%0.068%Search for SEC Filing on Google Icon
2/18/2026Commodore Capital LP1,475,000$59.59M4.0%-74.1%1.422%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.891,903$36.03M0.0%N/A0.860%Search for SEC Filing on Google Icon
2/18/2026Baker BROS. Advisors LP950,000$38.38M0.2%N/A0.916%Search for SEC Filing on Google Icon
2/18/2026Bridgeway Capital Management LLC31,000$1.25M0.0%-67.4%0.030%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC447,008$18.06M0.3%+149.9%0.431%Search for SEC Filing on Google Icon
2/18/2026Armistice Capital LLC172,479$6.97M0.1%N/A0.166%Search for SEC Filing on Google Icon
2/17/2026Logos Global Management LP750,000$30.30M1.8%N/A0.723%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC541,615$21.88M1.6%+5,316.2%0.522%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC754,237$30.47M0.1%-60.1%0.727%Search for SEC Filing on Google Icon
2/17/2026Burkehill Global Management LP40,000$1.62M0.1%N/A0.039%Search for SEC Filing on Google Icon
2/17/2026J. Goldman & Co LP203,192$8.21M0.2%N/A0.196%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC46,324$1.87M0.0%+15.3%0.045%Search for SEC Filing on Google Icon
2/17/2026Braidwell LP575,321$23.24M0.7%N/A0.554%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC6,395$0.26M0.1%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC95,124$3.84M0.0%N/A0.092%Search for SEC Filing on Google Icon
2/17/2026Paradigm Biocapital Advisors LP810,286$32.74M0.8%N/A0.781%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP150,049$6.06M0.1%+292.6%0.145%Search for SEC Filing on Google Icon
2/17/2026Nearwater Capital Markets Ltd1,704,800$68.87M1.2%N/A1.643%Search for SEC Filing on Google Icon
2/17/2026Farallon Capital Management LLC642,000$25.94M0.1%N/A0.619%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD974,312$39.36M0.0%+934.6%0.939%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP108,481$4.38M0.2%N/A0.105%Search for SEC Filing on Google Icon
2/17/2026Integral Health Asset Management LLC425,000$17.17M0.8%-55.3%0.410%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.5,550,000$224.22M0.3%+40.9%5.349%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.247,027$9.98M0.0%+667.8%0.238%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board25,874$1.05M0.0%-43.1%0.025%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC89,872$3.63M0.0%N/A0.087%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP375,673$15.18M0.1%N/A0.362%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada3,070$0.12M0.0%-80.5%0.003%Search for SEC Filing on Google Icon
2/17/2026Blair William & Co. IL6,050$0.24M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.10,958$0.44M0.0%-54.9%0.011%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC25,167$1.02M0.0%+97.6%0.024%Search for SEC Filing on Google Icon
2/16/2026Vanguard Personalized Indexing Management LLC18,555$0.75M0.0%+5.1%0.018%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC12,765$0.52M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC542,052$21.90M0.0%N/A0.522%Search for SEC Filing on Google Icon
2/16/2026Maven Securities LTD30,000$1.21M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/16/2026NEXTBio Capital Management LP551,190$22.27M13.1%N/A0.531%Search for SEC Filing on Google Icon
2/16/2026Nicholas Investment Partners LP165,781$6.70M0.5%N/A0.160%Search for SEC Filing on Google Icon
2/16/2026First Turn Management LLC872,049$35.23M4.0%N/A0.840%Search for SEC Filing on Google Icon
2/16/2026Healthcare of Ontario Pension Plan Trust Fund1,515,400$61.22M0.1%N/A1.460%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP11,620$0.47M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC171,186$6.92M0.0%+31.3%0.165%Search for SEC Filing on Google Icon
2/13/2026Prosight Management LP95,000$3.84M0.8%N/A0.105%Search for SEC Filing on Google Icon
2/13/2026FORA Capital LLC33,728$1.36M0.2%N/A0.037%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP878,583$35.50M0.0%N/A0.975%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 79,775$3.23M0.0%+220.1%0.089%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC28,057$1.13M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/13/2026Affinity Asset Advisors LLC550,000$22.22M1.3%N/A0.611%Search for SEC Filing on Google Icon
2/13/2026DLD Asset Management LP5,000$0.20M0.0%-50.0%0.006%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP81,034$3.27M0.0%N/A0.090%Search for SEC Filing on Google Icon
2/13/2026Vivo Capital LLC5,346,928$216.02M14.0%-22.5%5.936%Search for SEC Filing on Google Icon
2/13/2026Morgan Stanley7,945,608$321M0.0%+4.7%8.821%Search for SEC Filing on Google Icon
2/13/2026Schroder Investment Management Group99,360$4.03M0.0%-54.4%0.110%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC5,241$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/13/2026Alyeska Investment Group L.P.100,000$4.04M0.0%N/A0.111%Search for SEC Filing on Google Icon
2/13/2026Velan Capital Investment Management LP70,000$2.83M1.6%+250.0%0.078%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.737,160$29.78M0.0%+26.4%0.818%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey23,244$0.94M0.0%+5.4%0.026%Search for SEC Filing on Google Icon
2/13/2026State Street Corp1,775,922$71.75M0.0%+10.6%1.971%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC618$25K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/13/2026Polymer Capital Management HK LTD33,070$1.34M0.2%N/A0.037%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN96,308$3.89M0.0%+73.2%0.107%Search for SEC Filing on Google Icon
2/13/2026Platinum Investment Management Ltd.110,734$4.47M1.0%-11.5%0.123%Search for SEC Filing on Google Icon
2/13/2026Lord Abbett & CO. LLC2,712,399$109.58M0.3%N/A3.011%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP124,709$5.04M0.0%N/A0.138%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC47,938$1.94M0.0%+5.1%0.053%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp5,674$0.23M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC5,984$0.24M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/12/2026State Board of Administration of Florida Retirement System16,710$0.68M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC466,847$18.86M0.0%-31.0%0.518%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP1,247,763$50.41M0.0%-14.3%1.385%Search for SEC Filing on Google Icon
2/12/2026EntryPoint Capital LLC5,096$0.21M0.1%N/A0.006%Search for SEC Filing on Google Icon
2/12/2026Informed Momentum Co LLC108,986$4.40M0.5%N/A0.121%Search for SEC Filing on Google Icon
2/12/2026Patient Square Capital LP320,000$12.93M2.8%N/A0.355%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund65,303$2.64M0.0%+271.7%0.072%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Terns Pharmaceuticals logo
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Read More on Terns Pharmaceuticals

Today's Range

Now: $49.61
Low: $47.62
High: $50.89

50 Day Range

MA: $39.70
Low: $34.11
High: $49.13

52 Week Range

Now: $49.61
Low: $1.87
High: $50.89

Volume

3,605,060 shs

Average Volume

2,254,010 shs

Market Capitalization

$5.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Terns Pharmaceuticals?

Terns Pharmaceuticals' top insider shareholders include:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Amy L Burroughs (CEO)
  4. Vivo Opportunity, Llc (Major Shareholder)
  5. Mark J Vignola (CFO)
  6. Emil Kuriakose (Insider)
  7. Andrew Gengos (CFO)
  8. Jill M Quigley (Director)
  9. Melita Sun Jung (Insider)
  10. Jill M Quigley (Director)
Learn More about top insider investors at Terns Pharmaceuticals.

Who are the major institutional investors of Terns Pharmaceuticals?

Terns Pharmaceuticals' top institutional shareholders include:
  1. Morgan Stanley — 8.82%
  2. Adage Capital Partners GP L.L.C. — 5.35%
  3. Vanguard Group Inc. — 6.13%
  4. Vivo Capital LLC — 5.94%
  5. Vestal Point Capital LP — 4.34%
  6. Avoro Capital Advisors LLC — 4.19%
Learn More about top institutional investors of Terns Pharmaceuticals stock.

Which institutional investors are selling Terns Pharmaceuticals stock?

Within the last quarter, TERN stock was sold by these institutional investors:
  1. Orbimed Advisors LLC
  2. Commodore Capital LP
  3. Vivo Capital LLC
  4. Schonfeld Strategic Advisors LLC
  5. UBS Group AG
  6. Integral Health Asset Management LLC
  7. Nuveen LLC
  8. Superstring Capital Management LP
Within the last year, company insiders that have sold Terns Pharmaceuticals company stock include:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Amy L Burroughs (CEO)
Learn More investors selling Terns Pharmaceuticals stock.

Which institutional investors are buying Terns Pharmaceuticals stock?

In the previous quarter, TERN stock was acquired by institutional investors including:
  1. Vestal Point Capital LP
  2. Avoro Capital Advisors LLC
  3. Janus Henderson Group PLC
  4. Capitolis Liquid Global Markets LLC
  5. Lord Abbett & CO. LLC
  6. Nearwater Capital Markets Ltd
  7. Adage Capital Partners GP L.L.C.
  8. Healthcare of Ontario Pension Plan Trust Fund
During the last year, these company insiders have bought Terns Pharmaceuticals stock:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Amy L Burroughs (CEO)
  4. Vivo Opportunity, Llc (Major Shareholder)
Learn More investors buying Terns Pharmaceuticals stock.